Calm Restore Cream Base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

In cosmetic gels, emulsions, and washes, glycerin functions as a polyol humectant; its listed level is a guide.

3. Typical use levels (formulation guide)

• Gels and serums: 3–8% in this reference.
• The creams use-level reference is 2–5% for the formula.
• Rinse-off: 2–4% for the formula.

Incorporate Glycerin in the water phase without a separate melt step.

4. Regulatory sources & global compliance

• CosIng may identify Glycerin as an ingredient, but its entry does not approve a material grade or finished formula.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Glycerin for the product in its final form.
• Confirm the received Glycerin grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it provides no evidence that a drug or OTC monograph applies with patch response and finished-product stability still to be verified.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; match the pack choice to the system's oxidation risk; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Glycerin centers on humectant function.

• The development record does not support a drug effect, a clinical cure, or certification status not established for the SKU.
• The ingredient record for Glycerin provides no basis for whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane is a stable hydrocarbon emollient. The referenced grade is plant-derived, with mineral oil excluded.

3. Typical use levels (formulation guide)

• The formulation record indicates 2–6% for gel-creams in this reference.
• For dry oils, use 10–30% in this reference.
• For balms, use 5–15% for the formula.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• Database information on Squalane does not replace review of the supplied grade and finished product under market rules.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Squalane for the completed formula, not simply for an ingredient in isolation.
• For Squalane, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it is not evidence of drug approval or OTC authorization and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; take oxidation sensitivity into account when selecting the final pack; assess the confirmed formula for stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic role of Squalane is presented as a light-emollient role.

• The ingredient record provides no basis for drug effects, clinical cures, or unsupported product certifications.
• The cosmetic guidance for Squalane cannot establish skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The butter role is assigned to shea in creams, balms, and hair creams. The reference makes no assumption about unrefined color or scent.

3. Typical use levels (formulation guide)

• The level shown for creams is 2–8% for the formula.
• The formulation record indicates 10–25% for balms and butters.

The process note calls for melting Butyrospermum Parkii Butter into oil and cooling with shear so the butter does not grain.

4. Regulatory sources & global compliance

• The CosIng record for Butyrospermum Parkii Butter, where listed, is informational rather than product-specific authorization.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Butyrospermum Parkii Butter to undergo a safety assessment before release of the finished cosmetic.
• For Butyrospermum Parkii Butter, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing and the completed formula still requires stability and patch testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; review airless or pump options if oxidation presents a concern; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Butyrospermum Parkii Butter centers on shea cushion.

• The cosmetic listing does not demonstrate drug claims, cure claims, or a certification that is absent from the product records.
• The formulation record for Butyrospermum Parkii Butter does not demonstrate skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.